Yesterday
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
$159.88 / +17.55 (+12.33%)
05/02/22 Zscaler appoints Castle as Chief People Officer 04/13/22 Synchronoss appoints Stanley Lowe as chief information security officer 12/22/21 Zscaler officer Rajic sells $7.9M in company shares 12/20/21 Zscaler CFO sells $4.47M in common stock 05/24/22 Wendy's board to 'carefully review any proposal submitted by Trian Partners' 05/24/22 Wendy's up 15% to $18.70 following Trian 13D/A filing on potential transaction 05/24/22 Wendy's shareholder Trian to explore potential transaction 05/14/22 Trian exits Comcast position, increases stake in Invesco 05/26/22 Workday drops 7% to $155.50 after Q1 EPS misses estimates 05/16/22 Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe 02/28/22 Workday sees FY23 subscription revenue at $5.53B-$5.55B, up 22% y/y 02/14/22 Lone Pine takes stakes in Mastercard, Visa, exits Twitter, Meta Platforms 05/16/22 Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet 05/12/22 UnitedHealth selected by State of Missouri to serve Medicaid beneficiaries 04/26/22 Change says UnitedHealth to sell ClaimsXten for $2.2B if deal closes $425.30 / +47.685 (+12.63%)
05/26/22 Ulta Beauty jumps 7.6% to $406.50 after Q1 earnings beat and guidance raise 05/19/22 Ulta Beauty launches retail media network UB Media 03/28/22 PayPal broadens access to post purchase services for merchants 03/11/22 Ulta Beauty approves new $2B share repurchase authorization 05/27/22 Twitter board does not accept resignation of Silver Lake's Egon Durban 05/25/22 Twitter up 9% after Elon Musk files amended 13D related to takeover agreement 05/25/22 Musk commits to provide additional $6.25B in equity financing for Twitter deal 05/20/22 Elon Musk: We will never surrender/settle an unjust case against us $759.79 / +52.67 (+7.45%)
05/24/22 Cathie Wood's ARK Investment bought 26.1K shares of Tesla today 05/23/22 Cathie Wood's ARK Investment bought 15.9K shares of Tesla today 05/20/22 Musk denies he sexually harassed flight attendant on private jet 05/10/22 SoFi Technologies off lows after resumption, remains down 13% 05/10/22 SoFi Technologies trading resumes 05/10/22 SoFi Technologies to resume trading at 2:10 pm ET 05/10/22 SoFi Technologies CEO says 'off to a great start' standing up bank 03/24/22 Sallie Mae appoints William Wolf as CPO 01/26/22 Sallie Mae board approves new $1.25B share repurchase program 01/26/22 Sallie Mae to acquire Nitro College, terms not disclosed 05/19/22 Siga Technologies receives FDA approval for IV formulation of TPOXX 05/12/22 Siga Technologies awarded $7.5M Department of Defense contract 05/05/22 Siga Technologies announces special dividend of 45c per share 03/02/22 Siga Technologies announces start of TPOXX PEP clinical trials 05/26/22 PMV Pharmaceuticals: Lead program, PC14586 accepted as oral presentation at ASCO 04/27/22 PMV Pharmaceuticals to present initial PC14586 Phase 1 data at ASCO 04/21/22 Navient announces Lehman to leave board of directors 04/18/22 Navient, Sherborne Investors enter cooperation agreement 04/01/22 Navient sponsors USS Delaware commissioning commemoration event 02/14/22 Cooperman's Omega added Mirion, Discovery and Gan in Q4 05/09/22 Marvell to acquire Tanzanite in an all-cash transaction 04/20/22 Marvell appoints Sara Andrews to board of directors 04/14/22 Worldwide semiconductor revenue grew 26% in 2021, Gartner says 03/14/22 Marvell CEO: The company is performing extremely well $39.80 / -18.63 (-31.88%)
05/27/22 Mirati Therapeutics trading resumes 05/27/22 Mirati Therapeutics trading halted, volatility trading pause 05/26/22 Mirati Therapeutics says disease control rate was 80% in study 05/19/22 Mirati Therapeutics submits adagrasib MAA to EMA 05/26/22 Macy's rises 14.2% 05/26/22 Macy's rises 16.9% 05/26/22 Macy's jumps 12.5% to $21.61 after Q1 earnings beat 05/26/22 Macy's reports Q1 digital sales up 2% y/y and 34% q/q 05/20/22 iQIYI set to release 213 new pieces of content 04/25/22 iQIYI launches third set of digital collectibles 04/01/22 iQIYI to upgrade collaboration model for online film distribution 03/31/22 iQIYI provides update on status under HFCAA IOVA Iovance Biotherapeutics 05/26/22 Iovance announces clinical data for lifileucel in advanced melanoma 04/05/22 Iovance Biotherapeutics provides regulatory update on lifileucel 03/15/22 Iovance Biotherapeutics announces FDA allows IOV-4001 IND to proceed 01/10/22 Iovance appoints Raj Puri as EVP, regulatory strategy, translational medicine 05/27/22 Hibbett drops 7% to $47.50 after Q1 results miss estimates 05/27/22 Hibbett CEO says 'supply chain disruption has improved, inventory strong' 03/04/22 Hibbett reports Q4 SSS up 20.7% on two-year basis 03/04/22 Hibbett sees FY23 CapEx $60M-$70M 05/27/22 Gap falls -14.2% 05/27/22 Gap trading resumes 05/27/22 Gap trading halted, volatility trading pause 05/26/22 Gap falls 14% to $9.60 after Q1 earnings miss and guidance cut 05/27/22 Farfetch rises 22.8% 05/27/22 Farfetch rises 14.7% 05/26/22 Farfetch sees FY22 Digital GMV up 5%-10% and Brand Platform GMV up 10%-15% 04/05/22 Farfetch, Neiman Marcus Group announce global strategic partnership 05/23/22 Didi to proceed with delisting of shares from NYSE 05/16/22 Paulson exits Cerner, boosts Didi in Q1 04/17/22 DiDi to hold shareholder meeting on May 23 to vote on U.S. delisting plans 03/25/22 Didi falls -13.4% $49.57 / +5.715 (+13.03%)
05/27/22 Dell Technologies rises 14.2% 05/27/22 Dell Technologies rises 18.1% 05/26/22 Dell Technologies jumps 7% to $47.02 after Q1 results beat estimates 05/26/22 Dell Technologies ended Q1 with performance obligations of $42B 05/04/22 Costco reports April sales of $17.33B, up 13.9% 04/13/22 Costco increases quarterly cash dividend to 90c per share 04/06/22 Costco reports March sales of $21.61B, up 18.7% 03/08/22 Jones Soda's Fountain Syrup now sold at Costco Business Centers 05/27/22 Canopy Growth expects to be adjusted EBITDA positive in FY24 05/18/22 Canopy Growth announces plans to acquire Jetty Extracts 04/26/22 Canopy Growth expects to generate savings of $100M-$150M within 12-18 months 04/26/22 Canopy Growth announces cost reduction initiatives including headcount reduction 01/28/22 Boot Barn CEO: Plenty of opportunities to grow the business 01/27/22 Boot Barn sees FY22 CapEx $41M-$43M 05/27/22 Big Lots falls -10.3% 05/27/22 Big Lots falls -16.0% 05/27/22 Big Lots falls -11.7% 05/27/22 Big Lots drops 18% to $25.00 after Q1 results miss estimates 05/27/22 UBS Gap price target lowered to $11 from $14 at UBS 05/27/22 Deutsche Bank Gap price target lowered to $12 from $17 at Deutsche Bank 05/27/22 Wells Fargo Gap price target lowered to $16 from $20 at Wells Fargo 05/27/22 Baird Gap price target lowered to $11 from $14 at Baird 05/27/22 DA Davidson Workday price target lowered to $220 from $250 at DA Davidson 05/27/22 Stifel Workday price target lowered to $220 from $275 at Stifel 05/27/22 BMO Capital Workday price target lowered to $239 from $249 at BMO Capital 05/27/22 Needham Workday price target lowered to $200 from $300 at Needham $425.30 / +47.685 (+12.63%)
05/27/22 DA Davidson Ulta Beauty price target raised to $465 from $450 at DA Davidson 05/27/22 Oppenheimer Ulta Beauty price target raised to $485 from $470 at Oppenheimer 05/27/22 Jefferies Jefferies upgrades Ulta Beauty to Buy after 'signal we'd been waiting for' 05/27/22 Baird Ulta Beauty price target raised to $490 from $450 at Baird $49.57 / +5.715 (+13.03%)
05/27/22 BofA Dell Technologies price target raised to $67 from $65 at BofA 05/27/22 Morgan Stanley Dell Technologies price target lowered to $56 from $60 at Morgan Stanley 05/27/22 Deutsche Bank Dell Technologies price target lowered to $60 from $65 at Deutsche Bank 05/25/22 Evercore ISI Dell Technologies added to 'Tactical Outperform' list at Evercore ISI 05/27/22 Truist Costco price target raised to $543 from $503 at Truist 05/27/22 Baird Costco price target lowered to $560 from $600 at Baird 05/27/22 Credit Suisse Costco price target lowered to $550 from $570 at Credit Suisse 05/27/22 Loop Capital Costco price target lowered to $610 from $650 at Loop Capital 05/27/22 Baird Boot Barn upgraded to Outperform from Neutral at Baird 05/11/22 Craig-Hallum Boot Barn price target lowered to $145 from $162 at Craig-Hallum 05/11/22 JPMorgan Boot Barn added to Analyst Focus List at JPMorgan 05/06/22 Piper Sandler Boot Barn upgraded to Overweight from Neutral at Piper Sandler $159.88 / +17.55 (+12.33%)
05/27/22 Cowen Zscaler price target lowered to $194 from $405 at Cowen 05/27/22 Canaccord Zscaler price target lowered to $210 from $320 at Canaccord 05/27/22 BMO Capital Zscaler price target lowered to $172 from $270 at BMO Capital 05/27/22 Baird Zscaler price target lowered to $200 from $300 at Baird 05/27/22 BMO Capital Marvell price target lowered to $82 from $98 at BMO Capital 05/27/22 Needham Marvell price target lowered to $75 from $105 at Needham 05/27/22 BofA Marvell price target lowered to $90 from $100 at BofA 05/27/22 Cowen Marvell price target lowered to $85 from $100 at Cowen 05/25/22 Deutsche Bank Big Lots price target lowered to $31 from $44 at Deutsche Bank 05/24/22 BofA Big Lots price target lowered to $25 from $31 at BofA 05/20/22 Piper Sandler Big Lots price target lowered to $29 from $34 at Piper Sandler 05/10/22 JPMorgan Big Lots price target lowered to $25 from $31 at JPMorgan 05/20/22 Benchmark Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare 05/27/22 Deutsche Bank Macy's price target lowered to $29 from $34 at Deutsche Bank 05/27/22 Citi Macy's price target lowered to $23 from $25 at Citi 05/27/22 Morgan Stanley Macy's upgraded to Equal Weight from Underweight at Morgan Stanley 05/16/22 JPMorgan Macy's price target lowered to $30 from $33 at JPMorgan 05/27/22 Benchmark iQIYI upgraded to Buy from Hold at Benchmark 05/26/22 Citi Citi upgrades iQIYI on earlier than expected profitability 05/26/22 Citi iQIYI upgraded to Buy from Neutral at Citi 05/16/22 JPMorgan iQIYI upgraded to Overweight from Underweight at JPMorgan 05/26/22 Bernstein UnitedHealth downgraded to Market Perform at Bernstein on valuation 05/26/22 Bernstein UnitedHealth downgraded to Market Perform from Outperform at Bernstein 05/11/22 Citi MultiPlan price target raised to $6.50 from $6 at Citi 04/26/22 Piper Sandler Piper 'incrementally confident' Change, UNH will prevail in August 05/27/22 Alliance Global Partners Canopy Growth price target lowered to C$7 from C$8 at Alliance Global Partners 05/27/22 Benchmark Canopy Growth cut to Sell at Benchmark after 'disappointing' quarter 05/27/22 Benchmark Canopy Growth downgraded to Sell from Hold at Benchmark 05/20/22 Alliance Global Partners Canopy Growth price target lowered to C$8 from C$11 at Alliance Global Partners $15.65 / -0.1601 (-1.01%)
05/18/22 RBC Capital Reckitt Benckiser upgraded to Outperform from Sector Perform at RBC Capital 05/09/22 Morgan Stanley Reckitt Benckiser price target raised to 7,100 GBp at Morgan Stanley 05/03/22 RBC Capital Reckitt Benckiser price target raised to 5,900 GBp at RBC Capital 05/03/22 Barclays Reckitt Benckiser price target raised to 9,300 GBp from 9,100 GBp at Barclays 04/11/22 JPMorgan Navient cut to Underweight at JPMorgan on student lending normalization delay 04/11/22 JPMorgan Navient downgraded to Underweight from Neutral at JPMorgan 03/31/22 Compass Point Navient downgraded to Neutral from Buy at Compass Point 01/27/22 JPMorgan Navient price target lowered to $21 from $23 at JPMorgan 05/17/22 Mizuho SoFi Technologies price target lowered to $9 from $14 at Mizuho 05/16/22 Piper Sandler Piper upgrades SoFi to buy ahead of 'significant' earnings ramp 05/16/22 Piper Sandler SoFi Technologies upgraded to Overweight from Neutral at Piper Sandler 05/12/22 Citi SoFi Technologies price target lowered to $11 from $17 at Citi 01/13/22 Credit Suisse Nelnet downgraded to Neutral from Outperform at Credit Suisse 05/02/22 Citi Sallie Mae price target lowered to $21 from $26 at Citi 04/18/22 Stephens Sallie Mae downgraded to Equal Weight from Overweight at Stephens 01/10/22 Barclays Sallie Mae price target raised to $27 from $25 at Barclays 07/22/21 Stephens Stephens 'surprised' by Sallie Mae stock underperformance, ups target to $23 03/16/22 US Tiger China Internet sector upgraded to Outperform from Neutral at US Tiger 02/14/22 Bernstein Didi initiated with an Outperform at Bernstein 07/28/21 Alliance Global Partners Alliance Global Partners bullish on Aurora Mobile despite regulatory changes 07/28/21 Alliance Global Partners iClick Interactive price target lowered to $15 from $21 at Alliance Global 05/24/22 Jefferies Twitter price target lowered to $40 from $48 at Jefferies 05/24/22 Wedbush More fireworks expected heading into Twitter shareholder meeting, says Wedbush 05/24/22 KeyBanc Snap price target lowered to $27 from $45 at KeyBanc 05/24/22 Bernstein Bernstein says Tesla-Twitter saga far from over, discusses funding requirements $759.79 / +52.67 (+7.45%)
05/27/22 Credit Suisse Tesla pullback brings attractive entry point, says Credit Suisse 05/26/22 Jefferies Jefferies cuts Tesla price target on governance risk, challenging market 05/27/22 Wedbush Farfetch price target lowered to $8 from $16 at Wedbush 05/27/22 Morgan Stanley Farfetch price target lowered to $30 from $56 at Morgan Stanley 05/27/22 Wells Fargo Farfetch price target lowered to $25 from $35 at Wells Fargo 05/27/22 BTIG Farfetch price target lowered to $16 from $26 at BTIG 03/02/22 Oppenheimer Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target 03/02/22 Oppenheimer PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer 09/22/21 Goldman Sachs PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs 08/19/21 Oppenheimer PMV Pharmaceuticals initiated with a Perform at Oppenheimer IOVA Iovance Biotherapeutics 05/27/22 H.C. Wainwright Iovance Biotherapeutics 'close to the finish line,' says H.C. Wainwright 05/27/22 Oppenheimer Iovance Biotherapeutics price target lowered to $27 from $31 at Oppenheimer 05/27/22 Stifel Iovance Biotherapeutics after-hours stock reaction seems 'overdone,' says Stifel 05/27/22 Chardan Iovance Biotherapeutics price target lowered to $31 from $44 at Chardan $39.80 / -18.63 (-31.88%)
05/27/22 Stifel Mirati Therapeutics after-hours move lower 'overdone,' says Stifel 05/20/22 Guggenheim Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile' 05/20/22 Guggenheim Mirati Therapeutics upgraded to Buy from Neutral at Guggenheim 05/05/22 Stifel ASCO sets up as 'downside-biased' for Mirati investors, says Stifel 05/25/22 MKM Partners Wendy's may see more 'value unlocks' from strategic options, says MKM Partners 05/25/22 Wedbush Wedbush remains bullish on Wendy's, not surprised by Trian news 05/25/22 Stifel Wendy's deal in 'low-$20 range' would be 'feasible,' says Stifel 05/12/22 Truist Wendy's price target lowered to $27 from $29 at Truist 05/27/22 Baird Hibbett price target lowered to $70 from $75 at Baird 03/07/22 Benchmark Hibbett price target lowered to $80 from $125 at Benchmark 02/22/22 Monness Crespi Hibbett price target lowered to $80 from $120 at Monness Crespi 02/21/22 Baird Hibbett price target lowered to $75 from $100 at Baird $159.88 / +17.55 (+12.33%)
05/26/22 Zscaler sees FY22 EPS 64c-65c, consensus $55c 05/26/22 Zscaler sees Q4 EPS 20c-22c, consensus 17c 05/26/22 Zscaler reports Q3 EPS 17c, consensus 11c 05/26/22 Wendy's affirms FY22 EPS view at 82c-86c, consensus 83c, postpones Investor Day 05/11/22 Wendy's backs FY22 adjusted EPS view 82c-86c, consensus 87c 05/11/22 Wendy's reports Q1 adjusted EPS 17c, consensus 18c 05/10/22 Notable companies reporting before tomorrow's open 05/26/22 Workday sees Q2 subscription revenue $1.353B-$1.355B 05/26/22 Workday raises FY23 subscription revenue view to $5.537B-$5.557B 05/26/22 Workday reports Q1 EPS 83c, consensus 86c 04/14/22 UnitedHealth raises FY22 adjusted EPS view to $21.20-$21.70 from $21.10-$21.60 04/14/22 UnitedHealth reports Q1 adjusted EPS $5.49, consensus $5.38 04/13/22 Notable companies reporting before tomorrow's open $425.30 / +47.685 (+12.63%)
05/26/22 Ulta Beauty raises FY22 EPS view to $19.20-$20.10 from $18.20-$18.70 05/26/22 Ulta Beauty reports Q1 EPS $6.30, consensus $4.46 03/10/22 Ulta Beauty sees FY2 EPS $18.20-$18.70, consensus $17.84 04/28/22 Twitter withdrawing previously provided outlook given pending acquisition 04/28/22 Twitter reports Q1 EPS 90c, consensus 3c 02/10/22 Twitter expects FY22 revenue growth in low to mid 20's range 02/10/22 Twitter sees Q1 revenue $1.17B-$1.27B, consensus $1.26B $759.79 / +52.67 (+7.45%)
04/20/22 Tesla reports Q1 EPS $3.22, consensus $2.26 04/20/22 Notable companies reporting after market close 01/26/22 Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26 01/26/22 Notable companies reporting after market close 05/10/22 SoFi Technologies sees FY22 adjusted revenue $1.505B-$1.51B, consensus $1.46B 05/10/22 SoFi Technologies sees Q2 adjusted net revenue $330M-$340M, consensus $343.9M 05/10/22 SoFi Technologies reports Q1 EPS (14c), consensus (14c) 05/10/22 SoFi Technologies sees FY22 adjusted revenue $1.51B, Bloomberg says 04/27/22 Sallie Mae sees FY22 core EPS $2.80-$3.00, consensus $2.95 04/27/22 Sallie Mae reports Q1 core EPS 46c, consensus 82c 04/27/22 Notable companies reporting after market close 01/26/22 Sallie Mae reports Q4 core EPS $1.05, consensus 97c 03/03/22 Siga Technologies reports Q 4EPS 98c versus 26c last year 05/10/22 PMV Pharmaceuticals reports Q1 EPS (41c), consensus (40c) 03/01/22 PMV Pharmaceuticals reports 2021 EPS ($1.28), consensus ($1.22) 04/27/22 Navient raises FY22 EPS view to $3.20-$3.30 from $3.00-$3.15, consensus $3.03 04/26/22 Navient reports Q1 adjusted EPS 90c, consensus 75c 04/26/22 Notable companies reporting after market close 01/26/22 Navient sees FY22 EPS $3.00-$3.15, consensus $3.12 05/26/22 Marvell sees Q2 adjusted EPS 56c, +/- 3c per share, consensus 55c 05/26/22 Marvell reports Q1 adjusted EPS 52c, consensus 51c 03/03/22 Marvell sees Q1 adjusted EPS 51c +/- 3c, consensus 50c $39.80 / -18.63 (-31.88%)
02/28/22 Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00) 02/28/22 Mirati Therapeutics reports Q4 EPS ($3072), consensus ($3.00) 05/26/22 Macy's raises FY22 EPS view to $4.53-$4.95 from $4.13-$4.52, consensus $4.34 05/26/22 Macy's reports Q1 EPS $1.08, consensus 82c 05/25/22 Notable companies reporting before tomorrow's open 05/26/22 iQIYI reports Q1 EPS 3c, consensus (11c) 03/01/22 iQIYI reports Q4 EPS (20c), consensus (32c) IOVA Iovance Biotherapeutics 05/05/22 Iovance Biotherapeutics reports Q1 EPS (58c), consensus (64c) 05/27/22 Hibbett backs FY23 EPS view $9.75-$10.50, consensus $9.74 05/27/22 Hibbett reports Q1 EPS $2.89, consensus $3.08 03/04/22 Hibbett sees FY23 EPS $9.75-$10.50, consensus $9.85 03/04/22 Hibbett reports Q4 EPS $1.25, consensus $1.35 05/26/22 Gap cuts FY22 revenue view to down low-mid single digits from low single digits 05/26/22 Gap cuts FY22 EPS view to 30c-60c from $1.85-$2.05 05/26/22 Gap reports Q1 EPS (44c), consensus (13c) 05/26/22 Notable companies reporting after market close 05/26/22 Farfetch reports Q1 EPS (24c), consensus (28c) 02/24/22 Farfetch reports Q4 adjusted EPS (3c), consensus (3c) 12/29/21 Didi reports Q2 net loss (RMB 24.3B) vs. (RMB 63M) last year $49.57 / +5.715 (+13.03%)
05/26/22 Dell Technologies reports Q1 adjusted EPS $1.84, consensus $1.39 02/24/22 Dell Technologies reports Q4 adjusted EPS $1.72, consensus $1.95 02/24/22 Notable companies reporting after market close 05/26/22 Costco reports Q3 EPS $3.04, consensus $3.03 03/03/22 Costco reports Q2 EPS $2.92, consensus $2.74 03/03/22 Notable companies reporting after market close 05/27/22 Canopy Growth reports Q4 EPS (C$1.46) vs. (C$1.85) a year ago 04/07/22 Constellation Brands reports Q4 comparable EPS ex-Canopy losses $2.55 02/09/22 Canopy Growth reports Q3 EPS (C$0.28) vs. (C$2.43) a year ago 05/10/22 Boot Barn sees Q1 EPS $1.14, consensus $1.11 05/10/22 Boot Barn sees FY23 EPS $6.41, consensus $5.56 05/10/22 Boot Barn reports Q4 EPS $1.47, consensus $1.32 01/27/22 Boot Barn reports Q3 EPS $2.23 ex-items, consensus $2.22 05/27/22 Big Lots reports Q1 EPS (39c), consensus 93c 03/03/22 Big Lots sees Q1 adjusted EPS $1.10-$1.20, consensus $1.28 03/03/22 Big Lots reports Q4 adjusted EPS $1.75, consensus $1.89 01/10/22 Big Lots sees Q4 performance at 'upper end' of expectations
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
$157.14 / +14.81 (+10.41%)
05/02/22 Zscaler appoints Castle as Chief People Officer 04/13/22 Synchronoss appoints Stanley Lowe as chief information security officer 12/22/21 Zscaler officer Rajic sells $7.9M in company shares 12/20/21 Zscaler CFO sells $4.47M in common stock 05/24/22 Wendy's board to 'carefully review any proposal submitted by Trian Partners' 05/24/22 Wendy's up 15% to $18.70 following Trian 13D/A filing on potential transaction 05/24/22 Wendy's shareholder Trian to explore potential transaction 05/14/22 Trian exits Comcast position, increases stake in Invesco $152.90 / -15.16 (-9.02%)
05/26/22 Workday drops 7% to $155.50 after Q1 EPS misses estimates 05/16/22 Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe 02/28/22 Workday sees FY23 subscription revenue at $5.53B-$5.55B, up 22% y/y 02/14/22 Lone Pine takes stakes in Mastercard, Visa, exits Twitter, Meta Platforms 05/16/22 Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet 05/12/22 UnitedHealth selected by State of Missouri to serve Medicaid beneficiaries 04/26/22 Change says UnitedHealth to sell ClaimsXten for $2.2B if deal closes $414.47 / +36.855 (+9.76%)
05/26/22 Ulta Beauty jumps 7.6% to $406.50 after Q1 earnings beat and guidance raise 05/19/22 Ulta Beauty launches retail media network UB Media 03/28/22 PayPal broadens access to post purchase services for merchants 03/11/22 Ulta Beauty approves new $2B share repurchase authorization 05/27/22 Twitter board does not accept resignation of Silver Lake's Egon Durban 05/25/22 Twitter up 9% after Elon Musk files amended 13D related to takeover agreement 05/25/22 Musk commits to provide additional $6.25B in equity financing for Twitter deal 05/20/22 Elon Musk: We will never surrender/settle an unjust case against us $752.74 / +45.62 (+6.45%)
05/24/22 Cathie Wood's ARK Investment bought 26.1K shares of Tesla today 05/23/22 Cathie Wood's ARK Investment bought 15.9K shares of Tesla today 05/20/22 Musk denies he sexually harassed flight attendant on private jet 05/10/22 SoFi Technologies off lows after resumption, remains down 13% 05/10/22 SoFi Technologies trading resumes 05/10/22 SoFi Technologies to resume trading at 2:10 pm ET 05/10/22 SoFi Technologies CEO says 'off to a great start' standing up bank 03/24/22 Sallie Mae appoints William Wolf as CPO 01/26/22 Sallie Mae board approves new $1.25B share repurchase program 01/26/22 Sallie Mae to acquire Nitro College, terms not disclosed 05/19/22 Siga Technologies receives FDA approval for IV formulation of TPOXX 05/12/22 Siga Technologies awarded $7.5M Department of Defense contract 05/05/22 Siga Technologies announces special dividend of 45c per share 03/02/22 Siga Technologies announces start of TPOXX PEP clinical trials 05/26/22 PMV Pharmaceuticals: Lead program, PC14586 accepted as oral presentation at ASCO 04/27/22 PMV Pharmaceuticals to present initial PC14586 Phase 1 data at ASCO 04/21/22 Navient announces Lehman to leave board of directors 04/18/22 Navient, Sherborne Investors enter cooperation agreement 04/01/22 Navient sponsors USS Delaware commissioning commemoration event 02/14/22 Cooperman's Omega added Mirion, Discovery and Gan in Q4 05/09/22 Marvell to acquire Tanzanite in an all-cash transaction 04/20/22 Marvell appoints Sara Andrews to board of directors 04/14/22 Worldwide semiconductor revenue grew 26% in 2021, Gartner says 03/14/22 Marvell CEO: The company is performing extremely well $38.54 / -19.89 (-34.04%)
05/27/22 Mirati Therapeutics trading resumes 05/27/22 Mirati Therapeutics trading halted, volatility trading pause 05/26/22 Mirati Therapeutics says disease control rate was 80% in study 05/19/22 Mirati Therapeutics submits adagrasib MAA to EMA 05/26/22 Medtronic: Q1 EPS guidance includes FX headwind of about 5c 05/26/22 Medtronic: Procedure volumes in most markets reached pre-Covid levels by Q4E 05/26/22 Medtronic sees 'strong' improvement in 2H23, pipeline 'robust' 05/26/22 Medtronic: Parts of quarter played out as anticipated, but unexpected challenges 05/26/22 Macy's rises 14.2% 05/26/22 Macy's rises 16.9% 05/26/22 Macy's jumps 12.5% to $21.61 after Q1 earnings beat 05/26/22 Macy's reports Q1 digital sales up 2% y/y and 34% q/q 05/20/22 iQIYI set to release 213 new pieces of content 04/25/22 iQIYI launches third set of digital collectibles 04/01/22 iQIYI to upgrade collaboration model for online film distribution 03/31/22 iQIYI provides update on status under HFCAA IOVA Iovance Biotherapeutics 05/26/22 Iovance announces clinical data for lifileucel in advanced melanoma 04/05/22 Iovance Biotherapeutics provides regulatory update on lifileucel 03/15/22 Iovance Biotherapeutics announces FDA allows IOV-4001 IND to proceed 01/10/22 Iovance appoints Raj Puri as EVP, regulatory strategy, translational medicine 05/27/22 Hibbett drops 7% to $47.50 after Q1 results miss estimates 05/27/22 Hibbett CEO says 'supply chain disruption has improved, inventory strong' 03/04/22 Hibbett reports Q4 SSS up 20.7% on two-year basis 03/04/22 Hibbett sees FY23 CapEx $60M-$70M 05/27/22 Gap falls -14.2% 05/27/22 Gap trading resumes 05/27/22 Gap trading halted, volatility trading pause 05/26/22 Gap falls 14% to $9.60 after Q1 earnings miss and guidance cut 05/27/22 Farfetch rises 22.8% 05/27/22 Farfetch rises 14.7% 05/26/22 Farfetch sees FY22 Digital GMV up 5%-10% and Brand Platform GMV up 10%-15% 04/05/22 Farfetch, Neiman Marcus Group announce global strategic partnership 05/23/22 Didi to proceed with delisting of shares from NYSE 05/16/22 Paulson exits Cerner, boosts Didi in Q1 04/17/22 DiDi to hold shareholder meeting on May 23 to vote on U.S. delisting plans 03/25/22 Didi falls -13.4% 05/27/22 Dell Technologies rises 14.2% 05/27/22 Dell Technologies rises 18.1% 05/26/22 Dell Technologies jumps 7% to $47.02 after Q1 results beat estimates 05/26/22 Dell Technologies ended Q1 with performance obligations of $42B 05/04/22 Costco reports April sales of $17.33B, up 13.9% 04/13/22 Costco increases quarterly cash dividend to 90c per share 04/06/22 Costco reports March sales of $21.61B, up 18.7% 03/08/22 Jones Soda's Fountain Syrup now sold at Costco Business Centers 01/28/22 Boot Barn CEO: Plenty of opportunities to grow the business 01/27/22 Boot Barn sees FY22 CapEx $41M-$43M 05/27/22 Big Lots falls -10.3% 05/27/22 Big Lots falls -16.0% 05/27/22 Big Lots falls -11.7% 05/27/22 Big Lots drops 18% to $25.00 after Q1 results miss estimates 05/27/22 UBS Gap price target lowered to $11 from $14 at UBS 05/27/22 Deutsche Bank Gap price target lowered to $12 from $17 at Deutsche Bank 05/27/22 Wells Fargo Gap price target lowered to $16 from $20 at Wells Fargo 05/27/22 Baird Gap price target lowered to $11 from $14 at Baird $152.90 / -15.16 (-9.02%)
05/27/22 DA Davidson Workday price target lowered to $220 from $250 at DA Davidson 05/27/22 Stifel Workday price target lowered to $220 from $275 at Stifel 05/27/22 BMO Capital Workday price target lowered to $239 from $249 at BMO Capital 05/27/22 Needham Workday price target lowered to $200 from $300 at Needham $414.47 / +36.855 (+9.76%)
05/27/22 DA Davidson Ulta Beauty price target raised to $465 from $450 at DA Davidson 05/27/22 Oppenheimer Ulta Beauty price target raised to $485 from $470 at Oppenheimer 05/27/22 Jefferies Jefferies upgrades Ulta Beauty to Buy after 'signal we'd been waiting for' 05/27/22 Baird Ulta Beauty price target raised to $490 from $450 at Baird 05/27/22 BofA Dell Technologies price target raised to $67 from $65 at BofA 05/27/22 Morgan Stanley Dell Technologies price target lowered to $56 from $60 at Morgan Stanley 05/27/22 Deutsche Bank Dell Technologies price target lowered to $60 from $65 at Deutsche Bank 05/25/22 Evercore ISI Dell Technologies added to 'Tactical Outperform' list at Evercore ISI 05/27/22 Truist Costco price target raised to $543 from $503 at Truist 05/27/22 Baird Costco price target lowered to $560 from $600 at Baird 05/27/22 Credit Suisse Costco price target lowered to $550 from $570 at Credit Suisse 05/27/22 Loop Capital Costco price target lowered to $610 from $650 at Loop Capital 05/27/22 Baird Boot Barn upgraded to Outperform from Neutral at Baird 05/11/22 Craig-Hallum Boot Barn price target lowered to $145 from $162 at Craig-Hallum 05/11/22 JPMorgan Boot Barn added to Analyst Focus List at JPMorgan 05/06/22 Piper Sandler Boot Barn upgraded to Overweight from Neutral at Piper Sandler $157.14 / +14.81 (+10.41%)
05/27/22 Cowen Zscaler price target lowered to $194 from $405 at Cowen 05/27/22 Canaccord Zscaler price target lowered to $210 from $320 at Canaccord 05/27/22 BMO Capital Zscaler price target lowered to $172 from $270 at BMO Capital 05/27/22 Baird Zscaler price target lowered to $200 from $300 at Baird 05/27/22 BMO Capital Marvell price target lowered to $82 from $98 at BMO Capital 05/27/22 Needham Marvell price target lowered to $75 from $105 at Needham 05/27/22 BofA Marvell price target lowered to $90 from $100 at BofA 05/27/22 Cowen Marvell price target lowered to $85 from $100 at Cowen 05/25/22 Deutsche Bank Big Lots price target lowered to $31 from $44 at Deutsche Bank 05/24/22 BofA Big Lots price target lowered to $25 from $31 at BofA 05/20/22 Piper Sandler Big Lots price target lowered to $29 from $34 at Piper Sandler 05/10/22 JPMorgan Big Lots price target lowered to $25 from $31 at JPMorgan 05/20/22 Benchmark Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare 05/27/22 Deutsche Bank Macy's price target lowered to $29 from $34 at Deutsche Bank 05/27/22 Citi Macy's price target lowered to $23 from $25 at Citi 05/27/22 Morgan Stanley Macy's upgraded to Equal Weight from Underweight at Morgan Stanley 05/16/22 JPMorgan Macy's price target lowered to $30 from $33 at JPMorgan 05/27/22 Benchmark iQIYI upgraded to Buy from Hold at Benchmark 05/26/22 Citi Citi upgrades iQIYI on earlier than expected profitability 05/26/22 Citi iQIYI upgraded to Buy from Neutral at Citi 05/16/22 JPMorgan iQIYI upgraded to Overweight from Underweight at JPMorgan 05/26/22 Bernstein UnitedHealth downgraded to Market Perform at Bernstein on valuation 05/26/22 Bernstein UnitedHealth downgraded to Market Perform from Outperform at Bernstein 05/11/22 Citi MultiPlan price target raised to $6.50 from $6 at Citi 04/26/22 Piper Sandler Piper 'incrementally confident' Change, UNH will prevail in August 05/27/22 RBC Capital Medtronic price target lowered to $122 from $135 at RBC Capital 05/27/22 Cowen Medtronic price target lowered to $117 from $125 at Cowen 05/27/22 Needham Medtronic downgraded to Hold at Needham on slowing revenue growth 05/27/22 Deutsche Bank Medtronic price target lowered to $121 from $149 at Deutsche Bank 05/18/22 RBC Capital Reckitt Benckiser upgraded to Outperform from Sector Perform at RBC Capital 05/09/22 Morgan Stanley Reckitt Benckiser price target raised to 7,100 GBp at Morgan Stanley 05/03/22 RBC Capital Reckitt Benckiser price target raised to 5,900 GBp at RBC Capital 05/03/22 Barclays Reckitt Benckiser price target raised to 9,300 GBp from 9,100 GBp at Barclays 04/11/22 JPMorgan Navient cut to Underweight at JPMorgan on student lending normalization delay 04/11/22 JPMorgan Navient downgraded to Underweight from Neutral at JPMorgan 03/31/22 Compass Point Navient downgraded to Neutral from Buy at Compass Point 01/27/22 JPMorgan Navient price target lowered to $21 from $23 at JPMorgan 05/17/22 Mizuho SoFi Technologies price target lowered to $9 from $14 at Mizuho 05/16/22 Piper Sandler Piper upgrades SoFi to buy ahead of 'significant' earnings ramp 05/16/22 Piper Sandler SoFi Technologies upgraded to Overweight from Neutral at Piper Sandler 05/12/22 Citi SoFi Technologies price target lowered to $11 from $17 at Citi 01/13/22 Credit Suisse Nelnet downgraded to Neutral from Outperform at Credit Suisse 05/02/22 Citi Sallie Mae price target lowered to $21 from $26 at Citi 04/18/22 Stephens Sallie Mae downgraded to Equal Weight from Overweight at Stephens 01/10/22 Barclays Sallie Mae price target raised to $27 from $25 at Barclays 07/22/21 Stephens Stephens 'surprised' by Sallie Mae stock underperformance, ups target to $23 03/16/22 US Tiger China Internet sector upgraded to Outperform from Neutral at US Tiger 02/14/22 Bernstein Didi initiated with an Outperform at Bernstein 07/28/21 Alliance Global Partners Alliance Global Partners bullish on Aurora Mobile despite regulatory changes 07/28/21 Alliance Global Partners iClick Interactive price target lowered to $15 from $21 at Alliance Global 05/24/22 Jefferies Twitter price target lowered to $40 from $48 at Jefferies 05/24/22 Wedbush More fireworks expected heading into Twitter shareholder meeting, says Wedbush 05/24/22 KeyBanc Snap price target lowered to $27 from $45 at KeyBanc 05/24/22 Bernstein Bernstein says Tesla-Twitter saga far from over, discusses funding requirements $752.74 / +45.62 (+6.45%)
05/27/22 Credit Suisse Tesla pullback brings attractive entry point, says Credit Suisse 05/26/22 Jefferies Jefferies cuts Tesla price target on governance risk, challenging market 05/27/22 Wedbush Farfetch price target lowered to $8 from $16 at Wedbush 05/27/22 Morgan Stanley Farfetch price target lowered to $30 from $56 at Morgan Stanley 05/27/22 Wells Fargo Farfetch price target lowered to $25 from $35 at Wells Fargo 05/27/22 BTIG Farfetch price target lowered to $16 from $26 at BTIG 03/02/22 Oppenheimer Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target 03/02/22 Oppenheimer PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer 09/22/21 Goldman Sachs PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs 08/19/21 Oppenheimer PMV Pharmaceuticals initiated with a Perform at Oppenheimer IOVA Iovance Biotherapeutics 05/27/22 H.C. Wainwright Iovance Biotherapeutics 'close to the finish line,' says H.C. Wainwright 05/27/22 Oppenheimer Iovance Biotherapeutics price target lowered to $27 from $31 at Oppenheimer 05/27/22 Stifel Iovance Biotherapeutics after-hours stock reaction seems 'overdone,' says Stifel 05/27/22 Chardan Iovance Biotherapeutics price target lowered to $31 from $44 at Chardan $38.54 / -19.89 (-34.04%)
05/27/22 Stifel Mirati Therapeutics after-hours move lower 'overdone,' says Stifel 05/20/22 Guggenheim Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile' 05/20/22 Guggenheim Mirati Therapeutics upgraded to Buy from Neutral at Guggenheim 05/05/22 Stifel ASCO sets up as 'downside-biased' for Mirati investors, says Stifel 05/25/22 MKM Partners Wendy's may see more 'value unlocks' from strategic options, says MKM Partners 05/25/22 Wedbush Wedbush remains bullish on Wendy's, not surprised by Trian news 05/25/22 Stifel Wendy's deal in 'low-$20 range' would be 'feasible,' says Stifel 05/12/22 Truist Wendy's price target lowered to $27 from $29 at Truist 03/07/22 Benchmark Hibbett price target lowered to $80 from $125 at Benchmark 02/22/22 Monness Crespi Hibbett price target lowered to $80 from $120 at Monness Crespi 02/21/22 Baird Hibbett price target lowered to $75 from $100 at Baird 12/06/21 Fly Intel: Top five analyst upgrades $157.14 / +14.81 (+10.41%)
05/26/22 Zscaler sees FY22 EPS 64c-65c, consensus $55c 05/26/22 Zscaler sees Q4 EPS 20c-22c, consensus 17c 05/26/22 Zscaler reports Q3 EPS 17c, consensus 11c 05/26/22 Wendy's affirms FY22 EPS view at 82c-86c, consensus 83c, postpones Investor Day 05/11/22 Wendy's backs FY22 adjusted EPS view 82c-86c, consensus 87c 05/11/22 Wendy's reports Q1 adjusted EPS 17c, consensus 18c 05/10/22 Notable companies reporting before tomorrow's open $152.90 / -15.16 (-9.02%)
05/26/22 Workday sees Q2 subscription revenue $1.353B-$1.355B 05/26/22 Workday raises FY23 subscription revenue view to $5.537B-$5.557B 05/26/22 Workday reports Q1 EPS 83c, consensus 86c 04/14/22 UnitedHealth raises FY22 adjusted EPS view to $21.20-$21.70 from $21.10-$21.60 04/14/22 UnitedHealth reports Q1 adjusted EPS $5.49, consensus $5.38 04/13/22 Notable companies reporting before tomorrow's open $414.47 / +36.855 (+9.76%)
05/26/22 Ulta Beauty raises FY22 EPS view to $19.20-$20.10 from $18.20-$18.70 05/26/22 Ulta Beauty reports Q1 EPS $6.30, consensus $4.46 03/10/22 Ulta Beauty sees FY2 EPS $18.20-$18.70, consensus $17.84 04/28/22 Twitter withdrawing previously provided outlook given pending acquisition 04/28/22 Twitter reports Q1 EPS 90c, consensus 3c 02/10/22 Twitter expects FY22 revenue growth in low to mid 20's range 02/10/22 Twitter sees Q1 revenue $1.17B-$1.27B, consensus $1.26B $752.74 / +45.62 (+6.45%)
04/20/22 Tesla reports Q1 EPS $3.22, consensus $2.26 04/20/22 Notable companies reporting after market close 01/26/22 Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26 01/26/22 Notable companies reporting after market close 05/10/22 SoFi Technologies sees FY22 adjusted revenue $1.505B-$1.51B, consensus $1.46B 05/10/22 SoFi Technologies sees Q2 adjusted net revenue $330M-$340M, consensus $343.9M 05/10/22 SoFi Technologies reports Q1 EPS (14c), consensus (14c) 05/10/22 SoFi Technologies sees FY22 adjusted revenue $1.51B, Bloomberg says 04/27/22 Sallie Mae sees FY22 core EPS $2.80-$3.00, consensus $2.95 04/27/22 Sallie Mae reports Q1 core EPS 46c, consensus 82c 04/27/22 Notable companies reporting after market close 01/26/22 Sallie Mae reports Q4 core EPS $1.05, consensus 97c 03/03/22 Siga Technologies reports Q 4EPS 98c versus 26c last year 05/10/22 PMV Pharmaceuticals reports Q1 EPS (41c), consensus (40c) 03/01/22 PMV Pharmaceuticals reports 2021 EPS ($1.28), consensus ($1.22) 04/27/22 Navient raises FY22 EPS view to $3.20-$3.30 from $3.00-$3.15, consensus $3.03 04/26/22 Navient reports Q1 adjusted EPS 90c, consensus 75c 04/26/22 Notable companies reporting after market close 01/26/22 Navient sees FY22 EPS $3.00-$3.15, consensus $3.12 05/26/22 Marvell sees Q2 adjusted EPS 56c, +/- 3c per share, consensus 55c 05/26/22 Marvell reports Q1 adjusted EPS 52c, consensus 51c 03/03/22 Marvell sees Q1 adjusted EPS 51c +/- 3c, consensus 50c $38.54 / -19.89 (-34.04%)
02/28/22 Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00) 02/28/22 Mirati Therapeutics reports Q4 EPS ($3072), consensus ($3.00) 05/26/22 Medtronic sees Q1 organic revenue down 4.5%-5.5%, consensus $8.14B 05/26/22 Medtronic sees Q1 EPS $1.10-$1.14, consensus $1.40 05/26/22 Medtronic sees FY23 EPS $5.53-$5.65, consensus $5.82 05/26/22 Medtronic reports Q4 EPS $1.52, consensus $1.56 05/26/22 Macy's raises FY22 EPS view to $4.53-$4.95 from $4.13-$4.52, consensus $4.34 05/26/22 Macy's reports Q1 EPS $1.08, consensus 82c 05/25/22 Notable companies reporting before tomorrow's open 05/26/22 iQIYI reports Q1 EPS 3c, consensus (11c) 03/01/22 iQIYI reports Q4 EPS (20c), consensus (32c) IOVA Iovance Biotherapeutics 05/05/22 Iovance Biotherapeutics reports Q1 EPS (58c), consensus (64c) 05/27/22 Hibbett backs FY23 EPS view $9.75-$10.50, consensus $9.74 05/27/22 Hibbett reports Q1 EPS $2.89, consensus $3.08 03/04/22 Hibbett sees FY23 EPS $9.75-$10.50, consensus $9.85 03/04/22 Hibbett reports Q4 EPS $1.25, consensus $1.35 05/26/22 Gap cuts FY22 revenue view to down low-mid single digits from low single digits 05/26/22 Gap cuts FY22 EPS view to 30c-60c from $1.85-$2.05 05/26/22 Gap reports Q1 EPS (44c), consensus (13c) 05/26/22 Notable companies reporting after market close 05/26/22 Farfetch reports Q1 EPS (24c), consensus (28c) 02/24/22 Farfetch reports Q4 adjusted EPS (3c), consensus (3c) 12/29/21 Didi reports Q2 net loss (RMB 24.3B) vs. (RMB 63M) last year 05/26/22 Dell Technologies reports Q1 adjusted EPS $1.84, consensus $1.39 02/24/22 Dell Technologies reports Q4 adjusted EPS $1.72, consensus $1.95 02/24/22 Notable companies reporting after market close 05/26/22 Costco reports Q3 EPS $3.04, consensus $3.03 03/03/22 Costco reports Q2 EPS $2.92, consensus $2.74 03/03/22 Notable companies reporting after market close 05/10/22 Boot Barn sees Q1 EPS $1.14, consensus $1.11 05/10/22 Boot Barn sees FY23 EPS $6.41, consensus $5.56 05/10/22 Boot Barn reports Q4 EPS $1.47, consensus $1.32 01/27/22 Boot Barn reports Q3 EPS $2.23 ex-items, consensus $2.22 05/27/22 Big Lots reports Q1 EPS (39c), consensus 93c 03/03/22 Big Lots sees Q1 adjusted EPS $1.10-$1.20, consensus $1.28 03/03/22 Big Lots reports Q4 adjusted EPS $1.75, consensus $1.89 01/10/22 Big Lots sees Q4 performance at 'upper end' of expectations
Hot Stocks
Dell Technologies is up…
Dell Technologies is up 14.2%, or $6.22 to $50.16.
Show Hide Related Items >> <<
05/27/22 Dell Technologies rises 18.1% 05/26/22 Dell Technologies jumps 7% to $47.02 after Q1 results beat estimates 05/26/22 Dell Technologies ended Q1 with performance obligations of $42B 05/26/22 Dell Technologies co-COO calls Q1 a 'record first quarter' 05/27/22 BofA Dell Technologies price target raised to $67 from $65 at BofA 05/27/22 Morgan Stanley Dell Technologies price target lowered to $56 from $60 at Morgan Stanley 05/27/22 Deutsche Bank Dell Technologies price target lowered to $60 from $65 at Deutsche Bank 05/25/22 Evercore ISI Dell Technologies added to 'Tactical Outperform' list at Evercore ISI 05/26/22 Dell Technologies reports Q1 adjusted EPS $1.84, consensus $1.39 05/26/22 Notable companies reporting after market close 02/24/22 Dell Technologies reports Q4 adjusted EPS $1.72, consensus $1.95 02/24/22 Notable companies reporting after market close 05/22/22 Broadcom in talks to acquire VMware, Reuters reports 01/01/22 Amazon looks particularly attractive after wild year for tech, Barron's says 05/27/22 Fly Intel: Pre-market Movers 05/26/22 Fly Intel: After-Hours Movers 04/04/22 Fly Insider: TMC the Metals, Dell among week's notable insider trades 04/01/22 What You Missed On Wall Street On Friday 05/26/22 Dell Technologies options imply 6.3% move in share price post-earnings
Hot Stocks
Dell Technologies is up…
Dell Technologies is up 18.1%, or $7.94 to $51.87.
Show Hide Related Items >> <<
05/26/22 Dell Technologies jumps 7% to $47.02 after Q1 results beat estimates 05/26/22 Dell Technologies ended Q1 with performance obligations of $42B 05/26/22 Dell Technologies co-COO calls Q1 a 'record first quarter' 05/23/22 T-Mobile, Dell Technologies partner for 5G connectivity, edge compute 05/27/22 BofA Dell Technologies price target raised to $67 from $65 at BofA 05/27/22 Morgan Stanley Dell Technologies price target lowered to $56 from $60 at Morgan Stanley 05/27/22 Deutsche Bank Dell Technologies price target lowered to $60 from $65 at Deutsche Bank 05/25/22 Evercore ISI Dell Technologies added to 'Tactical Outperform' list at Evercore ISI 05/26/22 Dell Technologies reports Q1 adjusted EPS $1.84, consensus $1.39 05/26/22 Notable companies reporting after market close 02/24/22 Dell Technologies reports Q4 adjusted EPS $1.72, consensus $1.95 02/24/22 Notable companies reporting after market close 05/22/22 Broadcom in talks to acquire VMware, Reuters reports 01/01/22 Amazon looks particularly attractive after wild year for tech, Barron's says 05/27/22 Fly Intel: Pre-market Movers 05/26/22 Fly Intel: After-Hours Movers 04/04/22 Fly Insider: TMC the Metals, Dell among week's notable insider trades 04/01/22 What You Missed On Wall Street On Friday 05/26/22 Dell Technologies options imply 6.3% move in share price post-earnings
Downgrade
OTR Global downgraded its…
OTR Global downgraded its view on NetApp to Mixed from Positive following checks.
Show Hide Related Items >> <<
05/19/22 Kyndryl, NetApp announce alliance to fast-track cloud transition 05/10/22 NetApp teams with Nvidia to accelerate HPC/AI supercomputing infrastructure 04/07/22 NetApp to acquire Instaclustr 03/22/22 NetApp sees FY25E gross margin 69%-70% 05/25/22 JPMorgan NetApp price target lowered to $100 from $110 at JPMorgan 04/12/22 Morgan Stanley Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious 04/12/22 Morgan Stanley Morgan Stanley downgrades NetApp, sees challenging near-term setup 04/12/22 Morgan Stanley F5 Networks downgraded to Equal Weight, removed as 'Top Pick' at Morgan Stanley 03/22/22 NetApp sees FY25E revenue $7.98B-$8.4B, 8%-10% revenue CAGR 02/23/22 NetApp sees FY22 EPS $5.07-$5.17, consensus $5.06 02/23/22 NetApp sees Q4 EPS $$1.21-$1.31, consensus $1.35 02/23/22 NetApp reports Q3 EPS $1.44, consensus $1.28 04/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/24/22 What You Missed On Wall Street On Thursday 03/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/30/21 NetApp options imply 6.3% move in share price post-earnings
Thursday
On The Fly
Show Hide Related Items >> <<
05/26/22 Zymeworks to present zanidatamab antibody data at ASCO 05/20/22 Zymeworks rejects unsolicited acquisition proposal from All Blue Falcons FZE 05/04/22 Zymeworks expects cash to fund operations into second half of 2023 04/29/22 Zymeworks rises 31.7% 05/26/22 Workday drops 7% to $155.50 after Q1 EPS misses estimates 05/16/22 Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe 02/28/22 Workday sees FY23 subscription revenue at $5.53B-$5.55B, up 22% y/y 02/14/22 Lone Pine takes stakes in Mastercard, Visa, exits Twitter, Meta Platforms $378.10 / +25.03 (+7.09%)
05/26/22 Ulta Beauty jumps 7.6% to $406.50 after Q1 earnings beat and guidance raise 05/19/22 Ulta Beauty launches retail media network UB Media 03/28/22 PayPal broadens access to post purchase services for merchants SWTX SpringsWorks Therapeutics 05/24/22 SpringsWorks Therapeutics: Nirogacestat achieved endpoints in Phase 3 DeFi trial 04/19/22 SpringsWorks announces agreeement with Regeneron for nirogacestat 12/10/21 SpringsWorks Therapeutics announces trial collaboration with AbbVie 12/06/21 SpringsWorks Therapeutics doses first patient in Phase 1b/2 nirogacestat study 05/26/22 Red Robin jumps 13% to $9.76 after Q1 earnings beat 05/26/22 Red Robin backs FY22 adjusted EBITDA view of $90M-$90M 03/10/22 Red Robin sees FY22 adjusted EBITDA $80M-$90M 05/26/22 PMV Pharmaceuticals: Lead program, PC14586 accepted as oral presentation at ASCO 04/27/22 PMV Pharmaceuticals to present initial PC14586 Phase 1 data at ASCO 05/18/22 PDS Biotechnology appoints Sanjay Zaveri to SVP, business development 04/19/22 PDS Biotechnology receives $1.2M after selling NOL tax benefits 04/08/22 PDS Biotechnology reports inducement grants under Nasdaq listing rule 03/31/22 PDS Biotechnology expects cash to fund operations through end of 2023 05/09/22 Marvell to acquire Tanzanite in an all-cash transaction 04/20/22 Marvell appoints Sara Andrews to board of directors 04/14/22 Worldwide semiconductor revenue grew 26% in 2021, Gartner says 03/14/22 Marvell CEO: The company is performing extremely well 05/26/22 Mirati Therapeutics says disease control rate was 80% in study 05/19/22 Mirati Therapeutics submits adagrasib MAA to EMA 05/16/22 Mirati Therapeutics appoints Laurie Stelzer as CFO 03/21/22 AnaptysBio names Daniel Faga as interim CEO, succeeding Hamza Suria IOVA Iovance Biotherapeutics 05/26/22 Iovance announces clinical data for lifileucel in advanced melanoma 04/05/22 Iovance Biotherapeutics provides regulatory update on lifileucel 03/15/22 Iovance Biotherapeutics announces FDA allows IOV-4001 IND to proceed 01/10/22 Iovance appoints Raj Puri as EVP, regulatory strategy, translational medicine 05/26/22 Gap falls 14% to $9.60 after Q1 earnings miss and guidance cut 05/26/22 Gap reports Q1 SSS down 14% y/y 04/22/22 Gap falls -17.9% 04/22/22 Gap falls -22.2% 05/26/22 Dell Technologies jumps 7% to $47.02 after Q1 results beat estimates 05/26/22 Dell Technologies ended Q1 with performance obligations of $42B 05/26/22 Dell Technologies co-COO calls Q1 a 'record first quarter' 05/23/22 T-Mobile, Dell Technologies partner for 5G connectivity, edge compute $465.33 / +25.32 (+5.75%)
05/04/22 Costco reports April sales of $17.33B, up 13.9% 04/13/22 Costco increases quarterly cash dividend to 90c per share 04/06/22 Costco reports March sales of $21.61B, up 18.7% 03/08/22 Jones Soda's Fountain Syrup now sold at Costco Business Centers 05/26/22 American Eagle down 4% to $13.50 after lowering outlook for year 05/26/22 American Eagle CEO says committed to 'right-setting the business' 03/02/22 American Eagle says 'taking a cautious view of 2022' 12/29/21 American Eagle completes acquisition of Quiet Logistics 03/24/22 Autodesk to acquire The Wild, terms not disclosed 01/19/22 Autodesk acquires Moxion cloud solution 01/06/22 Autodesk names Rebecca Pearce Chief People Officer 12/16/21 Autodesk to acquire ProEst, terms not disclosed 05/26/22 Adicet Bio's ADI-001 shows 67% response rate for NHL in Phase 1 trial 04/19/22 Adicet Bio gets FDA fast track designation for lead candidate ADI-001 12/06/21 Adicet Bio trading resumes 12/06/21 Adicet Bio trading halted, volatility trading pause 04/18/22 Raymond James Red Robin downgraded to Market Perform from Outperform at Raymond James 04/18/22 Raymond James Red Robin downgraded to Market Perform from Outperform at Raymond James 11/23/21 Benchmark Red Robin initiated with a Buy at Benchmark 11/11/21 Raymond James Red Robin price target lowered to $30 from $40 at Raymond James $378.10 / +25.03 (+7.09%)
05/25/22 Deutsche Bank Ulta Beauty price target lowered to $466 from $522 at Deutsche Bank 04/19/22 Piper Sandler Ulta Beauty price target lowered to $465 from $475 at Piper Sandler 04/06/22 Piper Sandler Piper lists winners and losers from semi-annual teen survey 03/16/22 Oppenheimer Estee Lauder price target lowered to $300 from $350 at Oppenheimer 05/25/22 Evercore ISI Dell Technologies added to 'Tactical Outperform' list at Evercore ISI 05/25/22 JPMorgan Dell Technologies price target lowered to $60 from $68 at JPMorgan 05/23/22 Citi Dell Technologies price target lowered to $65 from $70 at Citi 04/19/22 KGI Securities Dell Technologies initiated with a Neutral at KGI Securities 05/25/22 Susquehanna Marvell price target lowered to $90 from $105 at Susquehanna 05/23/22 B. Riley Marvell price target lowered to $72 from $95 at B. Riley 05/23/22 UBS Marvell price target lowered to $80 from $95 at UBS 05/20/22 Oppenheimer Marvell price target lowered to $90 from $110 at Oppenheimer 05/23/22 Stifel Autodesk price target lowered to $230 from $285 at Stifel 05/23/22 RBC Capital Autodesk price target lowered to $255 from $295 at RBC Capital 05/23/22 Deutsche Bank Deutsche Bank downgrades Autodesk on risk to consensus estimates 05/23/22 Deutsche Bank Autodesk downgraded to Hold from Buy at Deutsche Bank 03/30/22 SMBC Nikko Adicet Bio initiated with an Outperform at SMBC Nikko 03/17/22 JMP Securities Adicet Bio price target lowered to $21 from $30 at JMP Securities 03/08/22 Truist Adicet Bio initiated with a Buy at Truist 03/04/22 Jefferies Adicet Bio initiated with a Buy at Jefferies 03/02/22 Oppenheimer Oppenheimer upgrades PMV Pharmaceuticals to Outperform with $30 price target 03/02/22 Oppenheimer PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer 09/22/21 Goldman Sachs PMV Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs 08/19/21 Oppenheimer PMV Pharmaceuticals initiated with a Perform at Oppenheimer 05/23/22 H.C. Wainwright Zymeworks price target lowered to $40 from $44 at H.C. Wainwright 05/09/22 Citi Zymeworks should reject 'opportunistic' $10.50 per share offer, says Citi 05/05/22 Guggenheim Zymeworks upgraded to Buy at Guggenheim amid low expectations 05/05/22 Guggenheim Zymeworks upgraded to Buy from Neutral at Guggenheim 05/13/22 Alliance Global Partners PDS Biotechnology price target lowered to $16 from $18 at Alliance Global Partners 10/21/21 H.C. Wainwright H.C. Wainwright says PDS Biotechnology temporary hold shouldn't spark concerns 08/12/21 H.C. Wainwright PDS Biotechnology price target lowered to $15 from $20 at H.C. Wainwright 06/28/21 Cantor Fitzgerald PDS Biotechnology initiated with an Overweight at Cantor Fitzgerald 05/23/22 Citi Gap downgraded to Sell from Neutral at Citi 05/17/22 UBS Gap price target lowered to $14 from $18 at UBS 05/16/22 JPMorgan Gap price target lowered to $11 from $14 at JPMorgan 04/25/22 Guggenheim Guggenheim upgrades Gap to Buy with shares 70% off highs 05/23/22 Citi American Eagle downgraded to Neutral from Buy at Citi 05/17/22 B. Riley American Eagle price target lowered to $32 from $41 at B. Riley 05/16/22 JPMorgan American Eagle price target lowered to $20 from $29 at JPMorgan 04/11/22 JPMorgan American Eagle price target lowered to $29 from $32 at JPMorgan 05/23/22 Cowen Workday price target lowered to $250 from $310 at Cowen 05/20/22 DA Davidson Workday price target lowered to $250 from $300 at DA Davidson 05/20/22 Barclays Workday price target lowered to $238 from $319 at Barclays 05/18/22 Wells Fargo Workday price target lowered to $300 from $340 at Wells Fargo $465.33 / +25.32 (+5.75%)
05/25/22 Deutsche Bank Costco price target lowered to $525 from $530 at Deutsche Bank 05/20/22 Oppenheimer Costco price target lowered to $500 from $645 at Oppenheimer 05/19/22 Truist Costco price target lowered to $503 from $634 at Truist 05/19/22 Stifel Costco price target lowered to $515 from $565 at Stifel IOVA Iovance Biotherapeutics 04/07/22 Truist Iovance Biotherapeutics price target lowered to $29 from $32 at Truist 04/07/22 Baird Iovance Biotherapeutics price target raised to $34 from $30 04/06/22 Oppenheimer Iovance 'good news' offset by timeline delay, says Oppenheimer 04/06/22 Goldman Sachs Iovance commentary supports potency assay progress, says Goldman Sachs SWTX SpringsWorks Therapeutics 05/24/22 Goldman Sachs SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs 03/01/22 H.C. Wainwright SpringsWorks Therapeutics price target raised to $142 from $137 at H.C. Wainwright 10/27/21 Wedbush Wedbush recommends buying SpringsWorks shares ahead of BLENREP combo data 09/08/21 JPMorgan SpringsWorks price target raised to $105 from $97 at JPMorgan 05/20/22 Guggenheim Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile' 05/20/22 Guggenheim Mirati Therapeutics upgraded to Buy from Neutral at Guggenheim 05/05/22 Stifel ASCO sets up as 'downside-biased' for Mirati investors, says Stifel 05/05/22 Citi Mirati Therapeutics price target lowered to $208 from $227 at Citi 05/04/22 Zymeworks reports Q1 adjusted EPS ($1.17), consensus ($1.67) 02/24/22 Zymeworks reports Q4 EPS (95c), consensus ($1.14) 05/26/22 Workday sees Q2 subscription revenue $1.353B-$1.355B 05/26/22 Workday raises FY23 subscription revenue view to $5.537B-$5.557B 05/26/22 Workday reports Q1 EPS 83c, consensus 86c $378.10 / +25.03 (+7.09%)
05/26/22 Ulta Beauty raises FY22 EPS view to $19.20-$20.10 from $18.20-$18.70 05/26/22 Ulta Beauty reports Q1 EPS $6.30, consensus $4.46 05/26/22 Notable companies reporting after market close 03/10/22 Ulta Beauty sees FY2 EPS $18.20-$18.70, consensus $17.84 SWTX SpringsWorks Therapeutics 05/05/22 SpringsWorks Therapeutics reports Q1 EPS ($1.26), consensus ($1.02) 02/24/22 SpringsWorks Therapeutics reports Q4 EPS ($1.15), consensus (88c) 05/26/22 Red Robin reports Q1 EPS (12c), consensus (73c) 03/10/22 Red Robin reports Q4 EPS ($1.36), consensus (53c) 05/10/22 PMV Pharmaceuticals reports Q1 EPS (41c), consensus (40c) 03/01/22 PMV Pharmaceuticals reports 2021 EPS ($1.28), consensus ($1.22) 05/11/22 PDS Biotechnology reports Q1 EPS (32c), consensus (22c) 03/31/22 PDS Biotechnology reports 2021 EPS (66c), consensus (71c) 05/26/22 Marvell sees Q2 adjusted EPS 56c, +/- 3c per share, consensus 55c 05/26/22 Marvell reports Q1 adjusted EPS 52c, consensus 51c 03/03/22 Marvell sees Q1 adjusted EPS 51c +/- 3c, consensus 50c 02/28/22 Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00) 02/28/22 Mirati Therapeutics reports Q4 EPS ($3072), consensus ($3.00) IOVA Iovance Biotherapeutics 05/05/22 Iovance Biotherapeutics reports Q1 EPS (58c), consensus (64c) 05/26/22 Gap cuts FY22 revenue view to down low-mid single digits from low single digits 05/26/22 Gap cuts FY22 EPS view to 30c-60c from $1.85-$2.05 05/26/22 Gap reports Q1 EPS (44c), consensus (13c) 05/26/22 Dell Technologies reports Q1 adjusted EPS $1.84, consensus $1.39 02/24/22 Dell Technologies reports Q4 adjusted EPS $1.72, consensus $1.95 02/24/22 Notable companies reporting after market close $465.33 / +25.32 (+5.75%)
05/26/22 Costco reports Q3 EPS $3.04, consensus $3.03 03/03/22 Costco reports Q2 EPS $2.92, consensus $2.74 03/03/22 Notable companies reporting after market close 05/26/22 American Eagle sees Q2 top-line growth to trend similarly to Q1 05/26/22 American Eagle reports Q1 EPS 16c, consensus 25c 03/02/22 American Eagle reports Q4 adjusted EPS 35c, consensus 35c 03/02/22 Notable companies reporting after market close 05/26/22 Autodesk sees FY23 non-GAAP EPS $6.43-$6.66, consensus $6.69 05/26/22 Autodesk sees Q2 non-GAAP EPS $1.54 - $1.60, consensus $1.60 05/26/22 Autodesk reports Q1 non-GAAP EPS $1.43, consensus $1.34 05/12/22 Adicet Bio reports Q1 EPS (12c), consensus (18c) 03/15/22 Adicet Bio reports Q4 EPS (47c), consensus (42c)